Found 82 hits Enz. Inhib. hit(s) with all data for entry = 50047269 Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Prostaglandin E2 receptor EP2 subtype
(Homo sapiens (Human)) | BDBM50156472
(CHEMBL3793167)Show SMILES [H][C@]12C[C@H](F)[C@H](COc3ccc(Cl)c(C)c3)[C@@]1([H])CC[C@@H](O2)c1nc(cs1)C(O)=O |r| Show InChI InChI=1S/C20H21ClFNO4S/c1-10-6-11(2-4-14(10)21)26-8-13-12-3-5-17(27-18(12)7-15(13)22)19-23-16(9-28-19)20(24)25/h2,4,6,9,12-13,15,17-18H,3,5,7-8H2,1H3,(H,24,25)/t12-,13-,15+,17-,18+/m1/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | 11 | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd
Curated by ChEMBL
| Assay Description Agonist activity at human EP2 receptor expressed in CHO cells assessed as cAMP level by HTRF assay |
Bioorg Med Chem Lett 26: 2446-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.03.110 BindingDB Entry DOI: 10.7270/Q2H41T90 |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP2 subtype
(Homo sapiens (Human)) | BDBM50156473
(CHEMBL3793724)Show SMILES [H][C@]12C[C@H](OC)[C@H](COc3ccc(Cl)c(C)c3)[C@@]1([H])CC[C@@H](O2)c1nc(cs1)C(O)=O |r| Show InChI InChI=1S/C21H24ClNO5S/c1-11-7-12(3-5-15(11)22)27-9-14-13-4-6-17(28-19(13)8-18(14)26-2)20-23-16(10-29-20)21(24)25/h3,5,7,10,13-14,17-19H,4,6,8-9H2,1-2H3,(H,24,25)/t13-,14-,17-,18+,19+/m1/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | 23 | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd
Curated by ChEMBL
| Assay Description Agonist activity at human EP2 receptor expressed in CHO cells assessed as cAMP level by HTRF assay |
Bioorg Med Chem Lett 26: 2446-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.03.110 BindingDB Entry DOI: 10.7270/Q2H41T90 |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP2 subtype
(Homo sapiens (Human)) | BDBM50156474
(CHEMBL3793515)Show SMILES [H][C@]12C[C@H](O)[C@H](COc3ccc(Cl)c(C)c3)[C@@]1([H])CC[C@@H](O2)c1nc(cs1)C(O)=O |r| Show InChI InChI=1S/C20H22ClNO5S/c1-10-6-11(2-4-14(10)21)26-8-13-12-3-5-17(27-18(12)7-16(13)23)19-22-15(9-28-19)20(24)25/h2,4,6,9,12-13,16-18,23H,3,5,7-8H2,1H3,(H,24,25)/t12-,13-,16+,17-,18+/m1/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL MMDB PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | 0.140 | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd
Curated by ChEMBL
| Assay Description Agonist activity at human EP2 receptor expressed in CHO cells assessed as cAMP level by HTRF assay |
Bioorg Med Chem Lett 26: 2446-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.03.110 BindingDB Entry DOI: 10.7270/Q2H41T90 |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP2 subtype
(Homo sapiens (Human)) | BDBM50156491
(CHEMBL3792668)Show SMILES [H][C@]12C[C@@H](O)[C@H](COc3ccc(Cl)c(C)c3)[C@@]1([H])CC[C@@H](O2)c1coc(c1)C(O)=O |r| Show InChI InChI=1S/C21H23ClO6/c1-11-6-13(2-4-16(11)22)26-10-15-14-3-5-18(28-19(14)8-17(15)23)12-7-20(21(24)25)27-9-12/h2,4,6-7,9,14-15,17-19,23H,3,5,8,10H2,1H3,(H,24,25)/t14-,15-,17-,18-,19+/m1/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | 55 | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd
Curated by ChEMBL
| Assay Description Agonist activity at human EP2 receptor expressed in CHO cells assessed as cAMP level by HTRF assay |
Bioorg Med Chem Lett 26: 2446-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.03.110 BindingDB Entry DOI: 10.7270/Q2H41T90 |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP2 subtype
(Homo sapiens (Human)) | BDBM50156528
(CHEMBL3794185)Show SMILES [H][C@]12C[C@@H](O)[C@H](COc3ccc(Cl)c(C)c3)[C@@]1([H])CC[C@@H](O2)c1csc(c1)C(O)=O |r| Show InChI InChI=1S/C21H23ClO5S/c1-11-6-13(2-4-16(11)22)26-9-15-14-3-5-18(27-19(14)8-17(15)23)12-7-20(21(24)25)28-10-12/h2,4,6-7,10,14-15,17-19,23H,3,5,8-9H2,1H3,(H,24,25)/t14-,15-,17-,18-,19+/m1/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | 114 | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd
Curated by ChEMBL
| Assay Description Agonist activity at human EP2 receptor expressed in CHO cells assessed as cAMP level by HTRF assay |
Bioorg Med Chem Lett 26: 2446-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.03.110 BindingDB Entry DOI: 10.7270/Q2H41T90 |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP2 subtype
(Homo sapiens (Human)) | BDBM50156529
(CHEMBL3794226)Show SMILES [H][C@]12C[C@@H](O)[C@H](COc3ccc(Cl)c(C)c3)[C@@]1([H])CC[C@@H](O2)c1ccc(o1)C(O)=O |r| Show InChI InChI=1S/C21H23ClO6/c1-11-8-12(2-4-15(11)22)26-10-14-13-3-5-17(28-20(13)9-16(14)23)18-6-7-19(27-18)21(24)25/h2,4,6-8,13-14,16-17,20,23H,3,5,9-10H2,1H3,(H,24,25)/t13-,14-,16-,17-,20+/m1/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | 2.20 | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd
Curated by ChEMBL
| Assay Description Agonist activity at human EP2 receptor expressed in CHO cells assessed as cAMP level by HTRF assay |
Bioorg Med Chem Lett 26: 2446-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.03.110 BindingDB Entry DOI: 10.7270/Q2H41T90 |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP2 subtype
(Homo sapiens (Human)) | BDBM50156530
(CHEMBL3793009)Show SMILES [H][C@]12C[C@@H](O)[C@H](COc3ccc(Cl)c(C)c3)[C@@]1([H])CC[C@@H](O2)c1nc(co1)C(O)=O |r| Show InChI InChI=1S/C20H22ClNO6/c1-10-6-11(2-4-14(10)21)26-8-13-12-3-5-17(28-18(12)7-16(13)23)19-22-15(9-27-19)20(24)25/h2,4,6,9,12-13,16-18,23H,3,5,7-8H2,1H3,(H,24,25)/t12-,13-,16-,17-,18+/m1/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | 15 | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd
Curated by ChEMBL
| Assay Description Agonist activity at human EP2 receptor expressed in CHO cells assessed as cAMP level by HTRF assay |
Bioorg Med Chem Lett 26: 2446-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.03.110 BindingDB Entry DOI: 10.7270/Q2H41T90 |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP2 subtype
(Homo sapiens (Human)) | BDBM50156531
(CHEMBL3792632)Show SMILES [H][C@]12C[C@@H](O)[C@H](COc3ccc(Cl)c(Cl)c3Cl)[C@@]1([H])CC[C@@H](O2)c1nc(cs1)C(O)=O |r| Show InChI InChI=1S/C19H18Cl3NO5S/c20-10-2-4-13(17(22)16(10)21)27-6-9-8-1-3-14(28-15(8)5-12(9)24)18-23-11(7-29-18)19(25)26/h2,4,7-9,12,14-15,24H,1,3,5-6H2,(H,25,26)/t8-,9-,12-,14-,15+/m1/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | 0.210 | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd
Curated by ChEMBL
| Assay Description Agonist activity at human EP2 receptor expressed in CHO cells assessed as cAMP level by HTRF assay |
Bioorg Med Chem Lett 26: 2446-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.03.110 BindingDB Entry DOI: 10.7270/Q2H41T90 |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP2 subtype
(Homo sapiens (Human)) | BDBM50156532
(CHEMBL3793862)Show SMILES [H][C@]12C[C@@H](O)[C@H](COc3cc(Cl)c(Cl)cc3Cl)[C@@]1([H])CC[C@@H](O2)c1nc(cs1)C(O)=O |r| Show InChI InChI=1S/C19H18Cl3NO5S/c20-10-3-12(22)17(4-11(10)21)27-6-9-8-1-2-15(28-16(8)5-14(9)24)18-23-13(7-29-18)19(25)26/h3-4,7-9,14-16,24H,1-2,5-6H2,(H,25,26)/t8-,9-,14-,15-,16+/m1/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | 0.200 | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd
Curated by ChEMBL
| Assay Description Agonist activity at human EP2 receptor expressed in CHO cells assessed as cAMP level by HTRF assay |
Bioorg Med Chem Lett 26: 2446-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.03.110 BindingDB Entry DOI: 10.7270/Q2H41T90 |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP2 subtype
(Homo sapiens (Human)) | BDBM50156533
(CHEMBL3794016)Show SMILES [H][C@]12C[C@@H](O)[C@H](COc3cc(C)c(Cl)c(C)c3)[C@@]1([H])CC[C@@H](O2)c1nc(cs1)C(O)=O |r| Show InChI InChI=1S/C21H24ClNO5S/c1-10-5-12(6-11(2)19(10)22)27-8-14-13-3-4-17(28-18(13)7-16(14)24)20-23-15(9-29-20)21(25)26/h5-6,9,13-14,16-18,24H,3-4,7-8H2,1-2H3,(H,25,26)/t13-,14-,16-,17-,18+/m1/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | 0.170 | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd
Curated by ChEMBL
| Assay Description Agonist activity at human EP2 receptor expressed in CHO cells assessed as cAMP level by HTRF assay |
Bioorg Med Chem Lett 26: 2446-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.03.110 BindingDB Entry DOI: 10.7270/Q2H41T90 |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP2 subtype
(Homo sapiens (Human)) | BDBM50156534
(CHEMBL3793809)Show SMILES [H][C@]12C[C@@H](O)[C@H](COc3ccc(c(C)c3)C(F)(F)F)[C@@]1([H])CC[C@@H](O2)c1nc(cs1)C(O)=O |r| Show InChI InChI=1S/C21H22F3NO5S/c1-10-6-11(2-4-14(10)21(22,23)24)29-8-13-12-3-5-17(30-18(12)7-16(13)26)19-25-15(9-31-19)20(27)28/h2,4,6,9,12-13,16-18,26H,3,5,7-8H2,1H3,(H,27,28)/t12-,13-,16-,17-,18+/m1/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | 3.90 | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd
Curated by ChEMBL
| Assay Description Agonist activity at human EP2 receptor expressed in CHO cells assessed as cAMP level by HTRF assay |
Bioorg Med Chem Lett 26: 2446-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.03.110 BindingDB Entry DOI: 10.7270/Q2H41T90 |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP2 subtype
(Homo sapiens (Human)) | BDBM50156535
(CHEMBL3793797)Show SMILES [H][C@]12C[C@@H](O)[C@H](COc3ccc(C)c(C)c3)[C@@]1([H])CC[C@@H](O2)c1nc(cs1)C(O)=O |r| Show InChI InChI=1S/C21H25NO5S/c1-11-3-4-13(7-12(11)2)26-9-15-14-5-6-18(27-19(14)8-17(15)23)20-22-16(10-28-20)21(24)25/h3-4,7,10,14-15,17-19,23H,5-6,8-9H2,1-2H3,(H,24,25)/t14-,15-,17-,18-,19+/m1/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | 2.90 | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd
Curated by ChEMBL
| Assay Description Agonist activity at human EP2 receptor expressed in CHO cells assessed as cAMP level by HTRF assay |
Bioorg Med Chem Lett 26: 2446-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.03.110 BindingDB Entry DOI: 10.7270/Q2H41T90 |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP2 subtype
(Homo sapiens (Human)) | BDBM50156536
(CHEMBL3794585)Show SMILES [H][C@]12C[C@@H](O)[C@H](COc3ccc(Cl)c(OC)c3)[C@@]1([H])CC[C@@H](O2)c1nc(cs1)C(O)=O |r| Show InChI InChI=1S/C20H22ClNO6S/c1-26-18-6-10(2-4-13(18)21)27-8-12-11-3-5-16(28-17(11)7-15(12)23)19-22-14(9-29-19)20(24)25/h2,4,6,9,11-12,15-17,23H,3,5,7-8H2,1H3,(H,24,25)/t11-,12-,15-,16-,17+/m1/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | 1.80 | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd
Curated by ChEMBL
| Assay Description Agonist activity at human EP2 receptor expressed in CHO cells assessed as cAMP level by HTRF assay |
Bioorg Med Chem Lett 26: 2446-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.03.110 BindingDB Entry DOI: 10.7270/Q2H41T90 |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP2 subtype
(Homo sapiens (Human)) | BDBM50156537
(CHEMBL3793020)Show SMILES [H][C@]12C[C@@H](O)[C@H](COc3ccc(Cl)c(c3)C(C)C)[C@@]1([H])CC[C@@H](O2)c1nc(cs1)C(O)=O |r| Show InChI InChI=1S/C22H26ClNO5S/c1-11(2)14-7-12(3-5-16(14)23)28-9-15-13-4-6-19(29-20(13)8-18(15)25)21-24-17(10-30-21)22(26)27/h3,5,7,10-11,13,15,18-20,25H,4,6,8-9H2,1-2H3,(H,26,27)/t13-,15-,18-,19-,20+/m1/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | 2 | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd
Curated by ChEMBL
| Assay Description Agonist activity at human EP2 receptor expressed in CHO cells assessed as cAMP level by HTRF assay |
Bioorg Med Chem Lett 26: 2446-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.03.110 BindingDB Entry DOI: 10.7270/Q2H41T90 |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP2 subtype
(Homo sapiens (Human)) | BDBM50156538
(CHEMBL3794466)Show SMILES [H][C@]12C[C@@H](O)[C@H](COc3ccc(Cl)c(CC)c3)[C@@]1([H])CC[C@@H](O2)c1nc(cs1)C(O)=O |r| Show InChI InChI=1S/C21H24ClNO5S/c1-2-11-7-12(3-5-15(11)22)27-9-14-13-4-6-18(28-19(13)8-17(14)24)20-23-16(10-29-20)21(25)26/h3,5,7,10,13-14,17-19,24H,2,4,6,8-9H2,1H3,(H,25,26)/t13-,14-,17-,18-,19+/m1/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | 0.680 | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd
Curated by ChEMBL
| Assay Description Agonist activity at human EP2 receptor expressed in CHO cells assessed as cAMP level by HTRF assay |
Bioorg Med Chem Lett 26: 2446-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.03.110 BindingDB Entry DOI: 10.7270/Q2H41T90 |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP2 subtype
(Homo sapiens (Human)) | BDBM50156539
(CHEMBL3793892)Show SMILES [H][C@]12C[C@@H](O)[C@H](COc3ccc(Cl)c(C)c3)[C@@]1([H])CC[C@@H](O2)c1nc(cs1)C(O)=O |r| Show InChI InChI=1S/C20H22ClNO5S/c1-10-6-11(2-4-14(10)21)26-8-13-12-3-5-17(27-18(12)7-16(13)23)19-22-15(9-28-19)20(24)25/h2,4,6,9,12-13,16-18,23H,3,5,7-8H2,1H3,(H,24,25)/t12-,13-,16-,17-,18+/m1/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
| Article PubMed
| n/a | n/a | n/a | n/a | 0.690 | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd
Curated by ChEMBL
| Assay Description Agonist activity at human EP2 receptor expressed in CHO cells assessed as cAMP level by HTRF assay |
Bioorg Med Chem Lett 26: 2446-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.03.110 BindingDB Entry DOI: 10.7270/Q2H41T90 |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP2 subtype
(Homo sapiens (Human)) | BDBM50156540
(CHEMBL3793802)Show SMILES [H][C@]12C[C@@H](O)[C@H](COc3ccc(Cl)c(Cl)c3)[C@@]1([H])CC[C@@H](O2)c1nc(cs1)C(O)=O |r| Show InChI InChI=1S/C19H19Cl2NO5S/c20-12-3-1-9(5-13(12)21)26-7-11-10-2-4-16(27-17(10)6-15(11)23)18-22-14(8-28-18)19(24)25/h1,3,5,8,10-11,15-17,23H,2,4,6-7H2,(H,24,25)/t10-,11-,15-,16-,17+/m1/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | 0.570 | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd
Curated by ChEMBL
| Assay Description Agonist activity at human EP2 receptor expressed in CHO cells assessed as cAMP level by HTRF assay |
Bioorg Med Chem Lett 26: 2446-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.03.110 BindingDB Entry DOI: 10.7270/Q2H41T90 |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP2 subtype
(Homo sapiens (Human)) | BDBM50156541
(CHEMBL3794302)Show SMILES [H][C@]12C[C@@H](O)[C@H](COc3ccc(Cl)c(c3)C(F)(F)F)[C@@]1([H])CC[C@@H](O2)c1nc(cs1)C(O)=O |r| Show InChI InChI=1S/C20H19ClF3NO5S/c21-13-3-1-9(5-12(13)20(22,23)24)29-7-11-10-2-4-16(30-17(10)6-15(11)26)18-25-14(8-31-18)19(27)28/h1,3,5,8,10-11,15-17,26H,2,4,6-7H2,(H,27,28)/t10-,11-,15-,16-,17+/m1/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | 0.110 | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd
Curated by ChEMBL
| Assay Description Agonist activity at human EP2 receptor expressed in CHO cells assessed as cAMP level by HTRF assay |
Bioorg Med Chem Lett 26: 2446-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.03.110 BindingDB Entry DOI: 10.7270/Q2H41T90 |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP2 subtype
(Homo sapiens (Human)) | BDBM50156542
(CHEMBL3793786)Show SMILES [H][C@]12C[C@@H](O)[C@H](COc3ccc(Cl)cc3)[C@@]1([H])CC[C@@H](O2)c1nc(cs1)C(O)=O |r| Show InChI InChI=1S/C19H20ClNO5S/c20-10-1-3-11(4-2-10)25-8-13-12-5-6-16(26-17(12)7-15(13)22)18-21-14(9-27-18)19(23)24/h1-4,9,12-13,15-17,22H,5-8H2,(H,23,24)/t12-,13-,15-,16-,17+/m1/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | 3.90 | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd
Curated by ChEMBL
| Assay Description Agonist activity at human EP2 receptor expressed in CHO cells assessed as cAMP level by HTRF assay |
Bioorg Med Chem Lett 26: 2446-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.03.110 BindingDB Entry DOI: 10.7270/Q2H41T90 |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP2 subtype
(Homo sapiens (Human)) | BDBM50156543
(CHEMBL3793045)Show SMILES [H][C@]12C[C@@H](O)[C@H](COc3cccc(c3)C(F)(F)F)[C@@]1([H])CC[C@@H](O2)c1nc(cs1)C(O)=O |r| Show InChI InChI=1S/C20H20F3NO5S/c21-20(22,23)10-2-1-3-11(6-10)28-8-13-12-4-5-16(29-17(12)7-15(13)25)18-24-14(9-30-18)19(26)27/h1-3,6,9,12-13,15-17,25H,4-5,7-8H2,(H,26,27)/t12-,13-,15-,16-,17+/m1/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | 0.900 | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd
Curated by ChEMBL
| Assay Description Agonist activity at human EP2 receptor expressed in CHO cells assessed as cAMP level by HTRF assay |
Bioorg Med Chem Lett 26: 2446-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.03.110 BindingDB Entry DOI: 10.7270/Q2H41T90 |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP2 subtype
(Homo sapiens (Human)) | BDBM50156544
(CHEMBL3793209)Show SMILES [H][C@]12C[C@@H](O)[C@H](COc3ccccc3)[C@@]1([H])CC[C@@H](O2)c1nc(cs1)C(O)=O |r| Show InChI InChI=1S/C19H21NO5S/c21-15-8-17-12(13(15)9-24-11-4-2-1-3-5-11)6-7-16(25-17)18-20-14(10-26-18)19(22)23/h1-5,10,12-13,15-17,21H,6-9H2,(H,22,23)/t12-,13-,15-,16-,17+/m1/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | 13 | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd
Curated by ChEMBL
| Assay Description Agonist activity at human EP2 receptor expressed in CHO cells assessed as cAMP level by HTRF assay |
Bioorg Med Chem Lett 26: 2446-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.03.110 BindingDB Entry DOI: 10.7270/Q2H41T90 |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP2 subtype
(Homo sapiens (Human)) | BDBM50156544
(CHEMBL3793209)Show SMILES [H][C@]12C[C@@H](O)[C@H](COc3ccccc3)[C@@]1([H])CC[C@@H](O2)c1nc(cs1)C(O)=O |r| Show InChI InChI=1S/C19H21NO5S/c21-15-8-17-12(13(15)9-24-11-4-2-1-3-5-11)6-7-16(25-17)18-20-14(10-26-18)19(22)23/h1-5,10,12-13,15-17,21H,6-9H2,(H,22,23)/t12-,13-,15-,16-,17+/m1/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd
Curated by ChEMBL
| Assay Description Agonist activity at human EP2 receptor expressed in HEK293 cells after 24 hrs beta-arrestin recruitment assay |
Bioorg Med Chem Lett 26: 2446-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.03.110 BindingDB Entry DOI: 10.7270/Q2H41T90 |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP2 subtype
(Homo sapiens (Human)) | BDBM50156543
(CHEMBL3793045)Show SMILES [H][C@]12C[C@@H](O)[C@H](COc3cccc(c3)C(F)(F)F)[C@@]1([H])CC[C@@H](O2)c1nc(cs1)C(O)=O |r| Show InChI InChI=1S/C20H20F3NO5S/c21-20(22,23)10-2-1-3-11(6-10)28-8-13-12-4-5-16(29-17(12)7-15(13)25)18-24-14(9-30-18)19(26)27/h1-3,6,9,12-13,15-17,25H,4-5,7-8H2,(H,26,27)/t12-,13-,15-,16-,17+/m1/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | 9 | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd
Curated by ChEMBL
| Assay Description Agonist activity at human EP2 receptor expressed in HEK293 cells after 24 hrs beta-arrestin recruitment assay |
Bioorg Med Chem Lett 26: 2446-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.03.110 BindingDB Entry DOI: 10.7270/Q2H41T90 |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP2 subtype
(Homo sapiens (Human)) | BDBM50156542
(CHEMBL3793786)Show SMILES [H][C@]12C[C@@H](O)[C@H](COc3ccc(Cl)cc3)[C@@]1([H])CC[C@@H](O2)c1nc(cs1)C(O)=O |r| Show InChI InChI=1S/C19H20ClNO5S/c20-10-1-3-11(4-2-10)25-8-13-12-5-6-16(26-17(12)7-15(13)22)18-21-14(9-27-18)19(23)24/h1-4,9,12-13,15-17,22H,5-8H2,(H,23,24)/t12-,13-,15-,16-,17+/m1/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd
Curated by ChEMBL
| Assay Description Agonist activity at human EP2 receptor expressed in HEK293 cells after 24 hrs beta-arrestin recruitment assay |
Bioorg Med Chem Lett 26: 2446-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.03.110 BindingDB Entry DOI: 10.7270/Q2H41T90 |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP2 subtype
(Homo sapiens (Human)) | BDBM50156541
(CHEMBL3794302)Show SMILES [H][C@]12C[C@@H](O)[C@H](COc3ccc(Cl)c(c3)C(F)(F)F)[C@@]1([H])CC[C@@H](O2)c1nc(cs1)C(O)=O |r| Show InChI InChI=1S/C20H19ClF3NO5S/c21-13-3-1-9(5-12(13)20(22,23)24)29-7-11-10-2-4-16(30-17(10)6-15(11)26)18-25-14(8-31-18)19(27)28/h1,3,5,8,10-11,15-17,26H,2,4,6-7H2,(H,27,28)/t10-,11-,15-,16-,17+/m1/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd
Curated by ChEMBL
| Assay Description Agonist activity at human EP2 receptor expressed in HEK293 cells after 24 hrs beta-arrestin recruitment assay |
Bioorg Med Chem Lett 26: 2446-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.03.110 BindingDB Entry DOI: 10.7270/Q2H41T90 |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP2 subtype
(Homo sapiens (Human)) | BDBM50156540
(CHEMBL3793802)Show SMILES [H][C@]12C[C@@H](O)[C@H](COc3ccc(Cl)c(Cl)c3)[C@@]1([H])CC[C@@H](O2)c1nc(cs1)C(O)=O |r| Show InChI InChI=1S/C19H19Cl2NO5S/c20-12-3-1-9(5-13(12)21)26-7-11-10-2-4-16(27-17(10)6-15(11)23)18-22-14(8-28-18)19(24)25/h1,3,5,8,10-11,15-17,23H,2,4,6-7H2,(H,24,25)/t10-,11-,15-,16-,17+/m1/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd
Curated by ChEMBL
| Assay Description Agonist activity at human EP2 receptor expressed in HEK293 cells after 24 hrs beta-arrestin recruitment assay |
Bioorg Med Chem Lett 26: 2446-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.03.110 BindingDB Entry DOI: 10.7270/Q2H41T90 |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP2 subtype
(Homo sapiens (Human)) | BDBM50156539
(CHEMBL3793892)Show SMILES [H][C@]12C[C@@H](O)[C@H](COc3ccc(Cl)c(C)c3)[C@@]1([H])CC[C@@H](O2)c1nc(cs1)C(O)=O |r| Show InChI InChI=1S/C20H22ClNO5S/c1-10-6-11(2-4-14(10)21)26-8-13-12-3-5-17(27-18(12)7-16(13)23)19-22-15(9-28-19)20(24)25/h2,4,6,9,12-13,16-18,23H,3,5,7-8H2,1H3,(H,24,25)/t12-,13-,16-,17-,18+/m1/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
| Article PubMed
| n/a | n/a | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd
Curated by ChEMBL
| Assay Description Agonist activity at human EP2 receptor expressed in HEK293 cells after 24 hrs beta-arrestin recruitment assay |
Bioorg Med Chem Lett 26: 2446-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.03.110 BindingDB Entry DOI: 10.7270/Q2H41T90 |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP2 subtype
(Homo sapiens (Human)) | BDBM50156538
(CHEMBL3794466)Show SMILES [H][C@]12C[C@@H](O)[C@H](COc3ccc(Cl)c(CC)c3)[C@@]1([H])CC[C@@H](O2)c1nc(cs1)C(O)=O |r| Show InChI InChI=1S/C21H24ClNO5S/c1-2-11-7-12(3-5-15(11)22)27-9-14-13-4-6-18(28-19(13)8-17(14)24)20-23-16(10-29-20)21(25)26/h3,5,7,10,13-14,17-19,24H,2,4,6,8-9H2,1H3,(H,25,26)/t13-,14-,17-,18-,19+/m1/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd
Curated by ChEMBL
| Assay Description Agonist activity at human EP2 receptor expressed in HEK293 cells after 24 hrs beta-arrestin recruitment assay |
Bioorg Med Chem Lett 26: 2446-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.03.110 BindingDB Entry DOI: 10.7270/Q2H41T90 |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP2 subtype
(Homo sapiens (Human)) | BDBM50156537
(CHEMBL3793020)Show SMILES [H][C@]12C[C@@H](O)[C@H](COc3ccc(Cl)c(c3)C(C)C)[C@@]1([H])CC[C@@H](O2)c1nc(cs1)C(O)=O |r| Show InChI InChI=1S/C22H26ClNO5S/c1-11(2)14-7-12(3-5-16(14)23)28-9-15-13-4-6-19(29-20(13)8-18(15)25)21-24-17(10-30-21)22(26)27/h3,5,7,10-11,13,15,18-20,25H,4,6,8-9H2,1-2H3,(H,26,27)/t13-,15-,18-,19-,20+/m1/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd
Curated by ChEMBL
| Assay Description Agonist activity at human EP2 receptor expressed in HEK293 cells after 24 hrs beta-arrestin recruitment assay |
Bioorg Med Chem Lett 26: 2446-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.03.110 BindingDB Entry DOI: 10.7270/Q2H41T90 |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP2 subtype
(Homo sapiens (Human)) | BDBM50156536
(CHEMBL3794585)Show SMILES [H][C@]12C[C@@H](O)[C@H](COc3ccc(Cl)c(OC)c3)[C@@]1([H])CC[C@@H](O2)c1nc(cs1)C(O)=O |r| Show InChI InChI=1S/C20H22ClNO6S/c1-26-18-6-10(2-4-13(18)21)27-8-12-11-3-5-16(28-17(11)7-15(12)23)19-22-14(9-29-19)20(24)25/h2,4,6,9,11-12,15-17,23H,3,5,7-8H2,1H3,(H,24,25)/t11-,12-,15-,16-,17+/m1/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd
Curated by ChEMBL
| Assay Description Agonist activity at human EP2 receptor expressed in HEK293 cells after 24 hrs beta-arrestin recruitment assay |
Bioorg Med Chem Lett 26: 2446-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.03.110 BindingDB Entry DOI: 10.7270/Q2H41T90 |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP2 subtype
(Homo sapiens (Human)) | BDBM50156535
(CHEMBL3793797)Show SMILES [H][C@]12C[C@@H](O)[C@H](COc3ccc(C)c(C)c3)[C@@]1([H])CC[C@@H](O2)c1nc(cs1)C(O)=O |r| Show InChI InChI=1S/C21H25NO5S/c1-11-3-4-13(7-12(11)2)26-9-15-14-5-6-18(27-19(14)8-17(15)23)20-22-16(10-28-20)21(24)25/h3-4,7,10,14-15,17-19,23H,5-6,8-9H2,1-2H3,(H,24,25)/t14-,15-,17-,18-,19+/m1/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd
Curated by ChEMBL
| Assay Description Agonist activity at human EP2 receptor expressed in HEK293 cells after 24 hrs beta-arrestin recruitment assay |
Bioorg Med Chem Lett 26: 2446-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.03.110 BindingDB Entry DOI: 10.7270/Q2H41T90 |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP2 subtype
(Homo sapiens (Human)) | BDBM50156534
(CHEMBL3793809)Show SMILES [H][C@]12C[C@@H](O)[C@H](COc3ccc(c(C)c3)C(F)(F)F)[C@@]1([H])CC[C@@H](O2)c1nc(cs1)C(O)=O |r| Show InChI InChI=1S/C21H22F3NO5S/c1-10-6-11(2-4-14(10)21(22,23)24)29-8-13-12-3-5-17(30-18(12)7-16(13)26)19-25-15(9-31-19)20(27)28/h2,4,6,9,12-13,16-18,26H,3,5,7-8H2,1H3,(H,27,28)/t12-,13-,16-,17-,18+/m1/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd
Curated by ChEMBL
| Assay Description Agonist activity at human EP2 receptor expressed in HEK293 cells after 24 hrs beta-arrestin recruitment assay |
Bioorg Med Chem Lett 26: 2446-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.03.110 BindingDB Entry DOI: 10.7270/Q2H41T90 |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP2 subtype
(Homo sapiens (Human)) | BDBM50156533
(CHEMBL3794016)Show SMILES [H][C@]12C[C@@H](O)[C@H](COc3cc(C)c(Cl)c(C)c3)[C@@]1([H])CC[C@@H](O2)c1nc(cs1)C(O)=O |r| Show InChI InChI=1S/C21H24ClNO5S/c1-10-5-12(6-11(2)19(10)22)27-8-14-13-3-4-17(28-18(13)7-16(14)24)20-23-15(9-29-20)21(25)26/h5-6,9,13-14,16-18,24H,3-4,7-8H2,1-2H3,(H,25,26)/t13-,14-,16-,17-,18+/m1/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | 2.30 | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd
Curated by ChEMBL
| Assay Description Agonist activity at human EP2 receptor expressed in HEK293 cells after 24 hrs beta-arrestin recruitment assay |
Bioorg Med Chem Lett 26: 2446-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.03.110 BindingDB Entry DOI: 10.7270/Q2H41T90 |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP2 subtype
(Homo sapiens (Human)) | BDBM50156532
(CHEMBL3793862)Show SMILES [H][C@]12C[C@@H](O)[C@H](COc3cc(Cl)c(Cl)cc3Cl)[C@@]1([H])CC[C@@H](O2)c1nc(cs1)C(O)=O |r| Show InChI InChI=1S/C19H18Cl3NO5S/c20-10-3-12(22)17(4-11(10)21)27-6-9-8-1-2-15(28-16(8)5-14(9)24)18-23-13(7-29-18)19(25)26/h3-4,7-9,14-16,24H,1-2,5-6H2,(H,25,26)/t8-,9-,14-,15-,16+/m1/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | 3.70 | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd
Curated by ChEMBL
| Assay Description Agonist activity at human EP2 receptor expressed in HEK293 cells after 24 hrs beta-arrestin recruitment assay |
Bioorg Med Chem Lett 26: 2446-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.03.110 BindingDB Entry DOI: 10.7270/Q2H41T90 |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP2 subtype
(Homo sapiens (Human)) | BDBM50156531
(CHEMBL3792632)Show SMILES [H][C@]12C[C@@H](O)[C@H](COc3ccc(Cl)c(Cl)c3Cl)[C@@]1([H])CC[C@@H](O2)c1nc(cs1)C(O)=O |r| Show InChI InChI=1S/C19H18Cl3NO5S/c20-10-2-4-13(17(22)16(10)21)27-6-9-8-1-3-14(28-15(8)5-12(9)24)18-23-11(7-29-18)19(25)26/h2,4,7-9,12,14-15,24H,1,3,5-6H2,(H,25,26)/t8-,9-,12-,14-,15+/m1/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | 2.30 | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd
Curated by ChEMBL
| Assay Description Agonist activity at human EP2 receptor expressed in HEK293 cells after 24 hrs beta-arrestin recruitment assay |
Bioorg Med Chem Lett 26: 2446-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.03.110 BindingDB Entry DOI: 10.7270/Q2H41T90 |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP2 subtype
(Homo sapiens (Human)) | BDBM50156530
(CHEMBL3793009)Show SMILES [H][C@]12C[C@@H](O)[C@H](COc3ccc(Cl)c(C)c3)[C@@]1([H])CC[C@@H](O2)c1nc(co1)C(O)=O |r| Show InChI InChI=1S/C20H22ClNO6/c1-10-6-11(2-4-14(10)21)26-8-13-12-3-5-17(28-18(12)7-16(13)23)19-22-15(9-27-19)20(24)25/h2,4,6,9,12-13,16-18,23H,3,5,7-8H2,1H3,(H,24,25)/t12-,13-,16-,17-,18+/m1/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd
Curated by ChEMBL
| Assay Description Agonist activity at human EP2 receptor expressed in HEK293 cells after 24 hrs beta-arrestin recruitment assay |
Bioorg Med Chem Lett 26: 2446-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.03.110 BindingDB Entry DOI: 10.7270/Q2H41T90 |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP2 subtype
(Homo sapiens (Human)) | BDBM50156529
(CHEMBL3794226)Show SMILES [H][C@]12C[C@@H](O)[C@H](COc3ccc(Cl)c(C)c3)[C@@]1([H])CC[C@@H](O2)c1ccc(o1)C(O)=O |r| Show InChI InChI=1S/C21H23ClO6/c1-11-8-12(2-4-15(11)22)26-10-14-13-3-5-17(28-20(13)9-16(14)23)18-6-7-19(27-18)21(24)25/h2,4,6-8,13-14,16-17,20,23H,3,5,9-10H2,1H3,(H,24,25)/t13-,14-,16-,17-,20+/m1/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd
Curated by ChEMBL
| Assay Description Agonist activity at human EP2 receptor expressed in HEK293 cells after 24 hrs beta-arrestin recruitment assay |
Bioorg Med Chem Lett 26: 2446-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.03.110 BindingDB Entry DOI: 10.7270/Q2H41T90 |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP2 subtype
(Homo sapiens (Human)) | BDBM50156528
(CHEMBL3794185)Show SMILES [H][C@]12C[C@@H](O)[C@H](COc3ccc(Cl)c(C)c3)[C@@]1([H])CC[C@@H](O2)c1csc(c1)C(O)=O |r| Show InChI InChI=1S/C21H23ClO5S/c1-11-6-13(2-4-16(11)22)26-9-15-14-3-5-18(27-19(14)8-17(15)23)12-7-20(21(24)25)28-10-12/h2,4,6-7,10,14-15,17-19,23H,3,5,8-9H2,1H3,(H,24,25)/t14-,15-,17-,18-,19+/m1/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd
Curated by ChEMBL
| Assay Description Agonist activity at human EP2 receptor expressed in HEK293 cells after 24 hrs beta-arrestin recruitment assay |
Bioorg Med Chem Lett 26: 2446-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.03.110 BindingDB Entry DOI: 10.7270/Q2H41T90 |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP2 subtype
(Homo sapiens (Human)) | BDBM50156491
(CHEMBL3792668)Show SMILES [H][C@]12C[C@@H](O)[C@H](COc3ccc(Cl)c(C)c3)[C@@]1([H])CC[C@@H](O2)c1coc(c1)C(O)=O |r| Show InChI InChI=1S/C21H23ClO6/c1-11-6-13(2-4-16(11)22)26-10-15-14-3-5-18(28-19(14)8-17(15)23)12-7-20(21(24)25)27-9-12/h2,4,6-7,9,14-15,17-19,23H,3,5,8,10H2,1H3,(H,24,25)/t14-,15-,17-,18-,19+/m1/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd
Curated by ChEMBL
| Assay Description Agonist activity at human EP2 receptor expressed in HEK293 cells after 24 hrs beta-arrestin recruitment assay |
Bioorg Med Chem Lett 26: 2446-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.03.110 BindingDB Entry DOI: 10.7270/Q2H41T90 |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP2 subtype
(Homo sapiens (Human)) | BDBM50156474
(CHEMBL3793515)Show SMILES [H][C@]12C[C@H](O)[C@H](COc3ccc(Cl)c(C)c3)[C@@]1([H])CC[C@@H](O2)c1nc(cs1)C(O)=O |r| Show InChI InChI=1S/C20H22ClNO5S/c1-10-6-11(2-4-14(10)21)26-8-13-12-3-5-17(27-18(12)7-16(13)23)19-22-15(9-28-19)20(24)25/h2,4,6,9,12-13,16-18,23H,3,5,7-8H2,1H3,(H,24,25)/t12-,13-,16+,17-,18+/m1/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL MMDB PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd
Curated by ChEMBL
| Assay Description Agonist activity at human EP2 receptor expressed in HEK293 cells after 24 hrs beta-arrestin recruitment assay |
Bioorg Med Chem Lett 26: 2446-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.03.110 BindingDB Entry DOI: 10.7270/Q2H41T90 |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP2 subtype
(Homo sapiens (Human)) | BDBM50156473
(CHEMBL3793724)Show SMILES [H][C@]12C[C@H](OC)[C@H](COc3ccc(Cl)c(C)c3)[C@@]1([H])CC[C@@H](O2)c1nc(cs1)C(O)=O |r| Show InChI InChI=1S/C21H24ClNO5S/c1-11-7-12(3-5-15(11)22)27-9-14-13-4-6-17(28-19(13)8-18(14)26-2)20-23-16(10-29-20)21(24)25/h3,5,7,10,13-14,17-19H,4,6,8-9H2,1-2H3,(H,24,25)/t13-,14-,17-,18+,19+/m1/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd
Curated by ChEMBL
| Assay Description Agonist activity at human EP2 receptor expressed in HEK293 cells after 24 hrs beta-arrestin recruitment assay |
Bioorg Med Chem Lett 26: 2446-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.03.110 BindingDB Entry DOI: 10.7270/Q2H41T90 |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP2 subtype
(Homo sapiens (Human)) | BDBM50156472
(CHEMBL3793167)Show SMILES [H][C@]12C[C@H](F)[C@H](COc3ccc(Cl)c(C)c3)[C@@]1([H])CC[C@@H](O2)c1nc(cs1)C(O)=O |r| Show InChI InChI=1S/C20H21ClFNO4S/c1-10-6-11(2-4-14(10)21)26-8-13-12-3-5-17(27-18(12)7-15(13)22)19-23-16(9-28-19)20(24)25/h2,4,6,9,12-13,15,17-18H,3,5,7-8H2,1H3,(H,24,25)/t12-,13-,15+,17-,18+/m1/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd
Curated by ChEMBL
| Assay Description Agonist activity at human EP2 receptor expressed in HEK293 cells after 24 hrs beta-arrestin recruitment assay |
Bioorg Med Chem Lett 26: 2446-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.03.110 BindingDB Entry DOI: 10.7270/Q2H41T90 |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP1 subtype
(Homo sapiens (Human)) | BDBM50156539
(CHEMBL3793892)Show SMILES [H][C@]12C[C@@H](O)[C@H](COc3ccc(Cl)c(C)c3)[C@@]1([H])CC[C@@H](O2)c1nc(cs1)C(O)=O |r| Show InChI InChI=1S/C20H22ClNO5S/c1-10-6-11(2-4-14(10)21)26-8-13-12-3-5-17(27-18(12)7-16(13)23)19-22-15(9-28-19)20(24)25/h2,4,6,9,12-13,16-18,23H,3,5,7-8H2,1H3,(H,24,25)/t12-,13-,16-,17-,18+/m1/s1 | KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
| Article PubMed
| n/a | n/a | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd
Curated by ChEMBL
| Assay Description Agonist activity at human EP1 receptor expressed in CHO cells assessed as intracellular Ca2+ level by fluorescence analysis |
Bioorg Med Chem Lett 26: 2446-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.03.110 BindingDB Entry DOI: 10.7270/Q2H41T90 |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP1 subtype
(Homo sapiens (Human)) | BDBM50156530
(CHEMBL3793009)Show SMILES [H][C@]12C[C@@H](O)[C@H](COc3ccc(Cl)c(C)c3)[C@@]1([H])CC[C@@H](O2)c1nc(co1)C(O)=O |r| Show InChI InChI=1S/C20H22ClNO6/c1-10-6-11(2-4-14(10)21)26-8-13-12-3-5-17(28-18(12)7-16(13)23)19-22-15(9-27-19)20(24)25/h2,4,6,9,12-13,16-18,23H,3,5,7-8H2,1H3,(H,24,25)/t12-,13-,16-,17-,18+/m1/s1 | KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd
Curated by ChEMBL
| Assay Description Agonist activity at human EP1 receptor expressed in CHO cells assessed as intracellular Ca2+ level by fluorescence analysis |
Bioorg Med Chem Lett 26: 2446-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.03.110 BindingDB Entry DOI: 10.7270/Q2H41T90 |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP1 subtype
(Homo sapiens (Human)) | BDBM50156529
(CHEMBL3794226)Show SMILES [H][C@]12C[C@@H](O)[C@H](COc3ccc(Cl)c(C)c3)[C@@]1([H])CC[C@@H](O2)c1ccc(o1)C(O)=O |r| Show InChI InChI=1S/C21H23ClO6/c1-11-8-12(2-4-15(11)22)26-10-14-13-3-5-17(28-20(13)9-16(14)23)18-6-7-19(27-18)21(24)25/h2,4,6-8,13-14,16-17,20,23H,3,5,9-10H2,1H3,(H,24,25)/t13-,14-,16-,17-,20+/m1/s1 | KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd
Curated by ChEMBL
| Assay Description Agonist activity at human EP1 receptor expressed in CHO cells assessed as intracellular Ca2+ level by fluorescence analysis |
Bioorg Med Chem Lett 26: 2446-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.03.110 BindingDB Entry DOI: 10.7270/Q2H41T90 |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP1 subtype
(Homo sapiens (Human)) | BDBM50156528
(CHEMBL3794185)Show SMILES [H][C@]12C[C@@H](O)[C@H](COc3ccc(Cl)c(C)c3)[C@@]1([H])CC[C@@H](O2)c1csc(c1)C(O)=O |r| Show InChI InChI=1S/C21H23ClO5S/c1-11-6-13(2-4-16(11)22)26-9-15-14-3-5-18(27-19(14)8-17(15)23)12-7-20(21(24)25)28-10-12/h2,4,6-7,10,14-15,17-19,23H,3,5,8-9H2,1H3,(H,24,25)/t14-,15-,17-,18-,19+/m1/s1 | KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd
Curated by ChEMBL
| Assay Description Agonist activity at human EP1 receptor expressed in CHO cells assessed as intracellular Ca2+ level by fluorescence analysis |
Bioorg Med Chem Lett 26: 2446-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.03.110 BindingDB Entry DOI: 10.7270/Q2H41T90 |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP1 subtype
(Homo sapiens (Human)) | BDBM50156491
(CHEMBL3792668)Show SMILES [H][C@]12C[C@@H](O)[C@H](COc3ccc(Cl)c(C)c3)[C@@]1([H])CC[C@@H](O2)c1coc(c1)C(O)=O |r| Show InChI InChI=1S/C21H23ClO6/c1-11-6-13(2-4-16(11)22)26-10-15-14-3-5-18(28-19(14)8-17(15)23)12-7-20(21(24)25)27-9-12/h2,4,6-7,9,14-15,17-19,23H,3,5,8,10H2,1H3,(H,24,25)/t14-,15-,17-,18-,19+/m1/s1 | KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd
Curated by ChEMBL
| Assay Description Agonist activity at human EP1 receptor expressed in CHO cells assessed as intracellular Ca2+ level by fluorescence analysis |
Bioorg Med Chem Lett 26: 2446-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.03.110 BindingDB Entry DOI: 10.7270/Q2H41T90 |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP1 subtype
(Homo sapiens (Human)) | BDBM50156474
(CHEMBL3793515)Show SMILES [H][C@]12C[C@H](O)[C@H](COc3ccc(Cl)c(C)c3)[C@@]1([H])CC[C@@H](O2)c1nc(cs1)C(O)=O |r| Show InChI InChI=1S/C20H22ClNO5S/c1-10-6-11(2-4-14(10)21)26-8-13-12-3-5-17(27-18(12)7-16(13)23)19-22-15(9-28-19)20(24)25/h2,4,6,9,12-13,16-18,23H,3,5,7-8H2,1H3,(H,24,25)/t12-,13-,16+,17-,18+/m1/s1 | KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL MMDB PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd
Curated by ChEMBL
| Assay Description Agonist activity at human EP1 receptor expressed in CHO cells assessed as intracellular Ca2+ level by fluorescence analysis |
Bioorg Med Chem Lett 26: 2446-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.03.110 BindingDB Entry DOI: 10.7270/Q2H41T90 |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP1 subtype
(Homo sapiens (Human)) | BDBM50156473
(CHEMBL3793724)Show SMILES [H][C@]12C[C@H](OC)[C@H](COc3ccc(Cl)c(C)c3)[C@@]1([H])CC[C@@H](O2)c1nc(cs1)C(O)=O |r| Show InChI InChI=1S/C21H24ClNO5S/c1-11-7-12(3-5-15(11)22)27-9-14-13-4-6-17(28-19(13)8-18(14)26-2)20-23-16(10-29-20)21(24)25/h3,5,7,10,13-14,17-19H,4,6,8-9H2,1-2H3,(H,24,25)/t13-,14-,17-,18+,19+/m1/s1 | KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd
Curated by ChEMBL
| Assay Description Agonist activity at human EP1 receptor expressed in CHO cells assessed as intracellular Ca2+ level by fluorescence analysis |
Bioorg Med Chem Lett 26: 2446-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.03.110 BindingDB Entry DOI: 10.7270/Q2H41T90 |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP1 subtype
(Homo sapiens (Human)) | BDBM50156472
(CHEMBL3793167)Show SMILES [H][C@]12C[C@H](F)[C@H](COc3ccc(Cl)c(C)c3)[C@@]1([H])CC[C@@H](O2)c1nc(cs1)C(O)=O |r| Show InChI InChI=1S/C20H21ClFNO4S/c1-10-6-11(2-4-14(10)21)26-8-13-12-3-5-17(27-18(12)7-15(13)22)19-23-16(9-28-19)20(24)25/h2,4,6,9,12-13,15,17-18H,3,5,7-8H2,1H3,(H,24,25)/t12-,13-,15+,17-,18+/m1/s1 | KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd
Curated by ChEMBL
| Assay Description Agonist activity at human EP1 receptor expressed in CHO cells assessed as intracellular Ca2+ level by fluorescence analysis |
Bioorg Med Chem Lett 26: 2446-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.03.110 BindingDB Entry DOI: 10.7270/Q2H41T90 |
More data for this Ligand-Target Pair | |